Winton Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
30,500
-4,200
-12% -$41.5K 0.01% 893
2026
Q1
$337K Buy
+34,700
New +$318K 0.01% 827
2022
Q4
Sell
-4,039
Closed -$245K 1015
2022
Q3
$245K Buy
+4,039
New +$128K 0.02% 847
2020
Q1
Sell
-16,257
Closed -$257K 1508
2019
Q4
$257K Buy
+16,257
New +$174K ﹤0.01% 1402

Other funds holding PRTA

Winton Group's PRTA Position: Q2 2026 in Review

Winton Group reduced its Prothena Corp (PRTA) stake by 12% in Q2 2026, selling an estimated $41.5K and leaving 30,500 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #893.

Winton Group first reported a position in PRTA in Q4 2019 and has held it in 4 quarters since. The position peaked at $337K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Winton Group held 30,500 shares of Prothena Corp worth $299K as of Q2 2026.
  • Winton Group sold 4,200 Prothena Corp shares in Q2 2026, an estimated $41.5K.
  • Prothena Corp made up 0.01% of Winton Group's portfolio in Q2 2026, its #893 holding.
  • Winton Group first reported a position in Prothena Corp in Q4 2019 and has held it in 4 quarters since.
  • Winton Group's Prothena Corp position peaked at $337K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.